New Risk Models May Reduce Unnecessary Prostate Biopsies
The new risk models improve upon PI-RADS version 1.0 and ERPSC risk calculators used for prostate biopsy decisions.
Diagnosis & Disease Information
New Nomogram Improves Post-RP Metastasis Predictions
Nomogram based on a cohort of men with high-risk prostate cancer is more accurate than the CAPRA and MSKCC nomograms, researchers report.
Prostatic Urethral Lift an Effective Option for Obstructed Patients
In a study, 86% of prostatic urethral lift patients experienced symptom relief in the first month.
Temperature-Related Kidney Stone Risk Higher Among Men
Differences in the effect of heat on evaporative water loss may help explain the disparity in kidney stone risk between men and women.
New Studies Confirm Advantages of Blue Light Cystoscopy
Steinberg: Two new studies show that blue light cystoscopy offers a significant advantage over white light cystoscopy identifying bladder tumors.
Staghorn Stone Composition Changes Reported
A single-center study found that most staghorn stones have a metabolic composition rather than an infectious cause.
Cholesterol Linked to High-Grade Prostate Cancer
Each 10 mg/dL increase in total cholesterol is associated with a significant 23% greater odds of high-grade prostate cancer.
Bone Metastasis at Diagnosis Predicts Early Prostate Cancer Mortality
Men who present with prostate cancer bone metastasis and no visceral metastases have a median survival time of 37 months, study finds.
Blue Light Cystoscopy Increases Bladder Cancer Detection Rate
Sensitivity is 90% for BLC compared with 75% for white light cystoscopy.
Bladder Cancer Recurrence Risk Lower in Metformin Users
The protective effect of the diabetes drug metformin among patients who undergo surgery for non-muscle invasive bladder cancer is dose dependent, according to a study.
- Loading...
Loading...
Next post in AUA 2017 Annual Meeting
Loading... 
Loading...